Genective, a global biotech solutions company, celebrated the Phase 2 expansion of its current lab space at Research Park in August 2022. The company added 30 percent more lab space to help accommodate its work in the agtech industry.
Genective specializes in the research, development, and commercialization of transgenic traits, specifically insect-resistant corn. The company manages to work across the value chain to create, deregulate and commercialize biotech corn traits. The added space will help the company to cultivate its innovative work in the biotech industry.